Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor

被引:76
|
作者
Miao, Yinglong [1 ,2 ]
Goldfeld, Dahlia Anne [2 ]
Von Moo, Ee [3 ]
Sexton, Patrick M. [3 ]
Christopoulos, Arthur [3 ]
McCammon, J. Andrew [1 ,2 ,4 ]
Valant, Celine [3 ]
机构
[1] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[3] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia
[4] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
基金
美国国家科学基金会; 英国医学研究理事会;
关键词
GPCR; allosteric modulators; ensemble docking; affinity; cooperativity; MOLECULAR-DYNAMICS SIMULATIONS; RELAXED COMPLEX SCHEME; ACETYLCHOLINE-RECEPTORS; DRUG DISCOVERY; INTERNATIONAL UNION; BINDING-SITES; ACTIVATION; TARGETS; CLASSIFICATION; PHARMACOLOGY;
D O I
10.1073/pnas.1612353113
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Design of ligands that provide receptor selectivity has emerged as a new paradigm for drug discovery of G protein-coupled receptors, and may, for certain families of receptors, only be achieved via identification of chemically diverse allosteric modulators. Here, the extracellular vestibule of the M-2 muscarinic acetylcholine receptor (mAChR) is targeted for structure-based design of allosteric modulators. Accelerated molecular dynamics (aMD) simulations were performed to construct structural ensembles that account for the receptor flexibility. Compounds obtained from the National Cancer Institute (NCI) were docked to the receptor ensembles. Retrospective docking of known ligands showed that combining aMD simulations with Glide induced fit docking (IFD) provided much-improved enrichment factors, compared with the Glide virtual screening workflow. Glide IFD was thus applied in receptor ensemble docking, and 38 top-ranked NCI compounds were selected for experimental testing. In [H-3]N-methylscopolamine radioligand dissociation assays, approximately half of the 38 lead compounds altered the radioligand dissociation rate, a hallmark of allosteric behavior. In further competition binding experiments, we identified 12 compounds with affinity of <= 30 mu M. With final functional experiments on six selected compounds, we confirmed four of them as new negative allosteric modulators (NAMs) and one as positive allosteric modulator of agonist-mediated response at the M-2 mAChR. Two of the NAMs showed subtype selectivity without significant effect at the M-1 and M-3 mAChRs. This study demonstrates an unprecedented successful structure-based approach to identify chemically diverse and selective GPCR allosteric modulators with outstanding potential for further structure-activity relationship studies.
引用
收藏
页码:E5675 / E5684
页数:10
相关论文
共 50 条
  • [41] Novobiocin and peptide analogs of α-factor are positive allosteric modulators of the yeast G protein-coupled receptor Ste2p
    Rymer, Jeffrey K.
    Hauser, Melinda
    Bourdon, Allen K.
    Campagna, Shawn R.
    Naider, Fred
    Becker, Jeffrey M.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2015, 1848 (04): : 916 - 924
  • [42] Accelerated molecular dynamics simulations of ligand binding to a muscarinic G-protein-coupled receptor
    Kappel, Kalli
    Miao, Yinglong
    McCammon, J. Andrew
    QUARTERLY REVIEWS OF BIOPHYSICS, 2015, 48 (04) : 479 - 487
  • [43] Sequential ligand- and structure-based virtual screening approach for the identification of potential G protein-coupled estrogen receptor-1 (GPER-1) modulators
    Khan, Shafi Ullah
    Ahemad, Nafees
    Chuah, Lay-Hong
    Naidu, Rakesh
    Htar, Thet Thet
    RSC ADVANCES, 2019, 9 (05) : 2525 - 2538
  • [44] Discovery and design of G protein-coupled receptor targeting antibodies
    Peterson, Sean. M. M.
    Hutchings, Catherine. J. J.
    Hu, Cameron. F. F.
    Mathur, Melina
    Salameh, Janelle. W. W.
    Axelrod, Fumiko
    Sato, Aaron. K. K.
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (04) : 417 - 428
  • [45] Structure-Function of the G Protein-Coupled Receptor Superfamily
    Katritch, Vsevolod
    Cherezov, Vadim
    Stevens, Raymond C.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013, 2013, 53 : 531 - 556
  • [46] Nanobodies to Study G Protein-Coupled Receptor Structure and Function
    Manglik, Aashish
    Kobilka, Brian K.
    Steyaert, Jan
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57, 2017, 57 : 19 - 37
  • [47] Relevance of G protein-coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
    Lopez-Balastegui, Marta
    Stepniewski, Tomasz Maciej
    Kogut-Guenthel, Malgorzata M.
    Di Pizio, Antonella
    Rosenkilde, Mette Marie
    Mao, Jiafei
    Selent, Jana
    BRITISH JOURNAL OF PHARMACOLOGY, 2024,
  • [48] Sequence, Structure and Ligand Binding Evolution of Rhodopsin-Like G Protein-Coupled Receptors: A Crystal Structure-Based Phylogenetic Analysis
    Wolf, Steffen
    Gruenewald, Stefan
    PLOS ONE, 2015, 10 (04):
  • [49] G Protein-Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
    Tsvetanova, Nikoleta G.
    Trester-Zedlitz, Michelle
    Newton, Billy W.
    Riordan, Daniel P.
    Sundaram, Aparna B.
    Johnson, Jeffrey R.
    Krogan, Nevan J.
    von Zastrow, Mark
    MOLECULAR PHARMACOLOGY, 2017, 91 (02) : 145 - 156
  • [50] High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening
    Qin, Shanshan
    Meng, Mengmeng
    Yang, Dehua
    Bai, Wenwen
    Lu, Yan
    Peng, Yao
    Song, Gaojie
    Wu, Yiran
    Zhou, Qingtong
    Zhao, Suwen
    Huang, Xiping
    McCorvy, John D.
    Cai, Xiaoqing
    Dai, Antao
    Roth, Bryan L.
    Hanson, Michael A.
    Liu, Zhi-Jie
    Wang, Ming-Wei
    Stevens, Raymond C.
    Shui, Wenqing
    CHEMICAL SCIENCE, 2018, 9 (12) : 3192 - 3199